Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00443573
Recruitment Status : Suspended (Company suspended development of product.)
First Posted : March 6, 2007
Last Update Posted : May 7, 2008
Sponsor:
Information provided by:
ARCA Biopharma, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : August 2007
Study Completion Date : No date given